Glycerol phosphate shuttle
Glycerol Phosphate Shuttle is a biochemical pathway that facilitates the transfer of reducing equivalents from the cytosol into the mitochondria to support the process of oxidative phosphorylation. This shuttle plays a crucial role in cellular energy metabolism, particularly in tissues such as muscle and brain, where rapid regeneration of ATP is necessary.
Overview
The glycerol phosphate shuttle is one of the mechanisms by which cells transfer NADH, produced during glycolysis in the cytosol, into the mitochondria. Since the mitochondrial membrane is impermeable to NADH, this shuttle provides an indirect route for the reducing equivalents to enter the mitochondria. It involves the oxidation of cytosolic NADH to NAD+ while reducing dihydroxyacetone phosphate (DHAP) to glycerol 3-phosphate (G3P). G3P is then oxidized back to DHAP in the mitochondrial membrane, transferring the electrons to the mitochondrial electron transport chain.
Mechanism
The glycerol phosphate shuttle involves two key enzymes: cytosolic glycerol-3-phosphate dehydrogenase (GPD1) and mitochondrial glycerol-3-phosphate dehydrogenase (GPD2). The shuttle operates as follows:
1. In the cytosol, GPD1 catalyzes the reduction of DHAP to G3P using NADH as the reducing agent, producing NAD+. 2. G3P is then transported to the mitochondrial membrane where GPD2 catalyzes the oxidation of G3P back to DHAP, transferring the electrons to FAD, forming FADH2. 3. FADH2 then donates electrons to the electron transport chain, ultimately contributing to the production of ATP.
Significance
The glycerol phosphate shuttle is particularly important in tissues with high metabolic rates, such as skeletal muscle and brain. It allows for the efficient transfer of reducing equivalents into the mitochondria, facilitating ATP production. However, it is less efficient than the Malate-Aspartate Shuttle in terms of the amount of ATP generated per NADH molecule because the electrons from NADH enter the electron transport chain at a lower energy level.
Comparison with Other Shuttles
The main alternative to the glycerol phosphate shuttle is the malate-aspartate shuttle, which is more efficient in terms of ATP yield but operates at a slower rate. The choice of shuttle used by a particular cell type depends on the balance between the need for rapid ATP regeneration and the maximum yield of ATP.
Clinical Relevance
Alterations in the glycerol phosphate shuttle have been implicated in various metabolic disorders and conditions such as diabetes and obesity. Understanding the regulation and function of this shuttle can provide insights into the metabolic changes associated with these conditions.
See Also
This article is a biochemistry stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD